What is the Buying Price of Aurobindo Pharma Share?

The Buying Price of Aurobindo Pharma share is 1463.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Aurobindo Pharma Share at Choice?

To buy Aurobindo Pharma stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aurobindo Pharma, choose your preferred order type, and place the trade.

What is the PE ratio of Aurobindo Pharma Shares?

The Price-to-earnings (P/E) ratio of Aurobindo Pharma shares is 23.65. You can compare it with the sector average for relative valuation.

What is the PB ratio of Aurobindo Pharma Shares?

The Price to Book (P/B) ratio Aurobindo Pharma shares is 2.19. Useful to assess the stock's value relative to its book value.

Is Aurobindo Pharma Overvalued?

To assess Aurobindo Pharma’s valuation compare Sector P/E, P/B which are 68.86 & 2.96 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Aurobindo Pharma?

The Market Cap of Aurobindo Pharma is 85006.13 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Aurobindo Pharma Share Price?

The 52 week high and low prices of Aurobindo Pharma share price is 1550 & 1016.1. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Aurobindo Pharma belong to?

Aurobindo Pharma belongs to the Healthcare sector.

Aurobindo Pharma Share price

AUROPHARMA

Healthcare Large Cap

1463.6

23.20 (1.61%)

NSE

BSE

Last updated on 4 Jun, 2026 | 15:52 IST

BuySell

Today's High

1482.00

Today's Low

1431.60

52 Week Low

1016.10

52 Week High

1550.00

Aurobindo Pharma Chart

ChartIQ

TradingView

Aurobindo Pharma Share Key Metrics

Volume

9.31 L

Market Cap

85006.13 CR

LTQ@LTP

2@1463.60

ATP

1463.56

Var Margin

14.49 %

Circuit Range

1296.4-1584.4

Delivery %

42.56 %

Value

136.31 CR

ASM/GSM

No

Market Lot

1

Summary

4 Jun, 2026 | 15:52 को, Aurobindo Pharma का शेयर प्राइस आज ₹1463.6 पर है, जो दिन के लिए 23.20% की 1.61 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1431.60 और ₹1482.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1016.10 से ₹1550.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Aurobindo Pharma ने 931335 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹580801623 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹146356 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 2,146360 रही। यह स्टॉक ₹1296.4-1584.4 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹136.31 CR है। दिन के लिए डिलीवरी परसेंटेज 42.56% रही। इसके अतिरिक्त, Aurobindo Pharma वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Aurobindo Pharma Fundamentals

P/E Ratio

23.65

P/B Ratio

2.19

Div. Yield

0.28

Sector P/E

68.86

Sector P/B

2.96

Sec. Div. Yield

0.54

Aurobindo Pharma Resistance and Support

Pivot 1439.2

Resistance

First Resistance

1459.2

Second Resistance

1478

Third Resistance

1498

Support

First Support

1420.4

Second Support

1400.4

Third Support

1381.6

Aurobindo Pharma Futures & Options

Aurobindo Pharma Ltd Share Price

1463.6

23.2 (1.61%)

Aurobindo Pharma Option Chain

View Price, OI, Greeks & More...

View All

30JUN26

1474.00

21.90 (1.51%)

28JUL26

1480.50

20.30 (1.39%)

25AUG26

1499.80

30.00 (2.04%)

AUROPHARMA|30JUN26 CE 1460.00

46.05 10.9 (31.01%)

AUROPHARMA|30JUN26 PE 1480.00

40.75 -13.5 (-24.88%)

Aurobindo Pharma Shareholding Pattern

2018-19
2020-21
2021-22
2022-23
2024-25
2026-27
2025-26
2023-24
2019-20
2016-17

Total Promoters

Segment

Percent

Total Promoters

53.79%

Mutual Fund

7.67%

Insurance

0.07%

Foreign Institutional Investors

26.12%

Domestic Institutional Investors

0.22%

Retail

12.13%

Others

0%

Total Promoters

JUN '16

53.79%

Aurobindo Pharma Corporate Actions

Date	Agenda
2026-05-21	Audited Results
2026-04-06	Buy Back of Shares
2026-02-09	Quarterly Results

Aurobindo Pharma News

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aurobindo Pharma received final US FDA approval to manufacture and market Tofacitinib Tablets, 5 mg and 10 mg. This allows immediate launch of the product in the US market, which has an estimated market size of US$494 million.

Jun 04 2026 18:16:02

Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata Motors

Aurobindo Pharma's unit, APL Healthcare Ltd, received a warning letter from the USFDA concerning its manufacturing facility in Hyderabad following an inspection conducted between July and August 2023.

Jun 04 2026 06:43:27

Stocks to Watch for June 4: Rajesh Exports, Aurobindo Pharma, IndiGo, NBCC and more

Aurobindo Pharma has been identified as a stock to watch for June 4, as per an article by CNBC TV18, indicating its inclusion in a list of companies that may be in focus for investors. The article, titled "Stocks to Watch for June 4", does not provide specific details on the reasons for this inclusion for Aurobindo Pharma.

Jun 03 2026 23:19:52

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aurobindo Pharma inaugurated TheraNym, a large-scale biologics contract manufacturing facility in Borapatla, Hyderabad. This marks the company's strategic entry into the high-growth biologics CMO segment, with global pharma giant MSD as an anchor customer.

Jun 03 2026 17:38:00

Aurobindo Pharma Limited

Aurobindo Pharma reported record Q4 and FY26 revenues and EBITDA, highlighting strong business performance across segments. The company projects FY27 EBITDA margins above 21% with plans for US business expansion.

May 27 2026 18:23:51

Aurobindo Pharma Limited

Aurobindo Pharma's wholly-owned subsidiary, Eugia Pharma Specialities Ltd., had its Unit-I formulation manufacturing facility classified as "Official Action Indicated" (OAI) by the US FDA. The facility was inspected from February 16-27, 2026, resulting in 4 observations.

May 24 2026 17:38:34

Aurobindo Pharma Ltd - 524804 - Classification Of Unit-I Of Eugia Pharma Specialities Limited, Shameerpet (Our Wholly Owned Subsidiary) As OAI

Aurobindo Pharma's wholly owned subsidiary, Eugia Pharma Specialities, has received an "Official Action Indicated" (OAI) classification from the US FDA for its Unit-I manufacturing facility. This classification follows an inspection that concluded with 4 observations, indicating that regulatory or administrative actions are recommended by the FDA.

May 24 2026 17:35:06

Rahul Shah bullish on pharma, sees Sun Pharma and Aurobindo as key large-cap plays

Expert Rahul Shah has expressed a bullish outlook on the pharmaceutical sector, specifically highlighting Aurobindo Pharma as a key large-cap investment opportunity, indicating positive sentiment for its future growth prospects.

May 22 2026 11:59:55

Explained - Why Aurobindo Pharma shares are trading with losses of over 5% on Friday

Aurobindo Pharma announced its consolidated financial results for Q4 FY26 and the full year ended March 31, 2026, reporting a 5.6% year-on-year increase in revenue from operations to ₹8,853 crore for the quarter, with a net profit of ₹921 crore. For the full fiscal year, total revenue reached ₹33,653 crore, a 6.1% increase. The company also highlighted strong segment performance in Europe Formulations, which grew by 30.2% year-on-year, and the completion of the Khandelwal laboratories acquisition for USD 317 million.

May 22 2026 11:50:06

Aurobindo Pharma Ltd - 524804 - Appointment Of Secretarial Auditor

Aurobindo Pharma announced a change in its Secretarial Auditors. M/s. MRR & Associates resigned due to health issues, and M/s. RPR & Associates has been appointed for a five-year term, subject to shareholder approval.

May 21 2026 21:02:34

Name	Position
Mangalam Ramasubramanian Kumar	Chairman
K Nityananda Reddy	Vice Chairman & Managing Director

Aurobindo Pharma Similar Stocks

Dr. Reddy's Laboratories Ltd.

1267.50

4.20 (0.33%)

Lupin Ltd.

2249.80

-11.40 (0.50%)

Mankind Pharma Ltd.

2353.00

-16.50 (0.70%)

Max Healthcare Institute Ltd.

966.20

0.65 (0.07%)

Lenskart Solutions Ltd.

513.05

-3.10 (0.60%)

Laurus Labs Ltd.

1427.20

32.90 (2.36%)

Fortis Healthcare Ltd.

940.65

10.40 (1.12%)

Biocon Ltd.

416.05

3.60 (0.87%)

Alkem Laboratories Ltd.

5276.50

2.50 (0.05%)

Glenmark Pharmaceuticals Ltd.

2180.60

6.60 (0.30%)

Aurobindo Pharma FAQs

Aurobindo Pharma शेयर का खरीद मूल्य 1463.6 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Aurobindo Pharma शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Aurobindo Pharma शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 23.65 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Aurobindo Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.19 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aurobindo Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.96 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aurobindo Pharma का मार्केट कैप 85006.13 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Aurobindo Pharma शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1550.00 और 1016.10 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।